5-Ethynyluracil (GW776): effects on the formation of the toxic catabolites of 5-fluorouracil, fluoroacetate and fluorohydroxypropionic acid in the isolated perfused rat liver model
1997

Effects of 5-Ethynyluracil on 5-Fluorouracil Metabolism

Sample size: 9 publication Evidence: high

Author Information

Author(s): M Arellano, M Malet-Martinol, R Martino, T Spector

Primary Institution: Universite Paul Sabatier

Hypothesis

GW776 modulates the metabolism of 5-fluorouracil to reduce the formation of toxic metabolites.

Conclusion

GW776 significantly reduces the formation of toxic compounds from 5-fluorouracil, potentially mitigating its side effects.

Supporting Evidence

  • GW776 reduced the amount of 5-FU catabolites by a factor of 27.
  • Unmetabolized 5-FU represented 94% of the fluorinated compounds measured with GW776.
  • FBAL formation decreased by a factor of approximately 110 with GW776.
  • 5-FU anabolites increased by a factor of approximately 7 in the presence of GW776.
  • GW776 may help mitigate the cardiotoxic and neurotoxic side effects of 5-FU.

Takeaway

This study shows that a drug called GW776 can help reduce the harmful effects of another drug, 5-fluorouracil, which is used to treat cancer.

Methodology

The study used isolated perfused rat liver models to analyze the effects of GW776 on the metabolism of 5-fluorouracil.

Limitations

The study was conducted in a rat model, which may not fully represent human metabolism.

Participant Demographics

Male Wistar rats were used in the experiments.

Statistical Information

P-Value

<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication